BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15138447)

  • 1. Regulation of working memory by dopamine D4 receptor in rats.
    Zhang K; Grady CJ; Tsapakis EM; Andersen SL; Tarazi FI; Baldessarini RJ
    Neuropsychopharmacology; 2004 Sep; 29(9):1648-55. PubMed ID: 15138447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
    Costanza RM; Barber DJ; Terry P
    Psychopharmacology (Berl); 2001 Nov; 158(2):146-53. PubMed ID: 11702088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine D4 receptor antagonist L-745,870: effects in rats discriminating cocaine from saline.
    Costanza RM; Terry P
    Eur J Pharmacol; 1998 Mar; 345(2):129-32. PubMed ID: 9600627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The selective dopamine D4 receptor antagonist, PNU-101387G, prevents stress-induced cognitive deficits in monkeys.
    Arnsten AF; Murphy B; Merchant K
    Neuropsychopharmacology; 2000 Oct; 23(4):405-10. PubMed ID: 10989267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitatory effect of the dopamine D4 receptor agonist PD168,077 on memory consolidation of an inhibitory avoidance learned response in C57BL/6J mice.
    Bernaerts P; Tirelli E
    Behav Brain Res; 2003 Jun; 142(1-2):41-52. PubMed ID: 12798264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
    Romo-Parra H; Aceves J; GutiƩrrez R
    Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions.
    Zhang K; Davids E; Tarazi FI; Baldessarini RJ
    Psychopharmacology (Berl); 2002 Apr; 161(1):100-6. PubMed ID: 11967637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
    Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI
    J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
    Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting.
    Floresco SB; Magyar O; Ghods-Sharifi S; Vexelman C; Tse MT
    Neuropsychopharmacology; 2006 Feb; 31(2):297-309. PubMed ID: 16012531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers.
    Mehta MA; Hinton EC; Montgomery AJ; Bantick RA; Grasby PM
    J Psychopharmacol; 2005 Jan; 19(1):29-38. PubMed ID: 15671126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D4 receptors inhibit depolarization-induced [3H]GABA release in the rat subthalamic nucleus.
    Floran B; Floran L; Erlij D; Aceves J
    Eur J Pharmacol; 2004 Sep; 498(1-3):97-102. PubMed ID: 15363981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dopamine and its antagonists on directional delay-period activity of prefrontal neurons in monkeys during an oculomotor delayed-response task.
    Sawaguchi T
    Neurosci Res; 2001 Oct; 41(2):115-28. PubMed ID: 11591439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some dopamine antagonists on spatial memory performance in rats--experimental research.
    Rusu G; Popa G; Ochiuz L; Nechifor M; Tartau L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):116-24. PubMed ID: 24741787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex.
    Chudasama Y; Robbins TW
    Neuropsychopharmacology; 2004 Sep; 29(9):1628-36. PubMed ID: 15138446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of dopamine D4 receptor affinity contributes to the procognitive effect of lurasidone.
    Murai T; Nakako T; Ikeda K; Ikejiri M; Ishiyama T; Taiji M
    Behav Brain Res; 2014 Mar; 261():26-30. PubMed ID: 24304719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-[4-(3,4-Dimethylphenyl)piperazin-1-ylmethyl]-1H benzoimidazole (A-381393), a selective dopamine D4 receptor antagonist.
    Nakane M; Cowart MD; Hsieh GC; Miller L; Uchic ME; Chang R; Terranova MA; Donnelly-Roberts DL; Namovic MT; Miller TR; Wetter JM; Marsh K; Stewart AO; Brioni JD; Moreland RB
    Neuropharmacology; 2005 Jul; 49(1):112-21. PubMed ID: 15992586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.